Surgical Science Sweden AB (publ)

OM:SUS Rapport sur les actions

Capitalisation boursière : SEK 6.4b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Surgical Science Sweden Gestion

Gestion contrôle des critères 4/4

Le PDG Surgical Science Sweden's est Gisli Hennermark, nommé en Sep2015, a un mandat de 8.92 ans. La rémunération annuelle totale est SEK 5.83M, composée du salaire de 73.7% et des bonus 26.3%, y compris les actions et options de la société. détient directement 0.67% des actions de la société, d'une valeur de SEK 45.82M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.6 ans et 5.4 ans.

Informations clés

Gisli Hennermark

Directeur général

SEK 5.8m

Rémunération totale

Pourcentage du salaire du PDG73.7%
Durée du mandat du directeur général8.9yrs
Propriété du PDG0.7%
Durée moyenne d'occupation des postes de direction3.6yrs
Durée moyenne du mandat des membres du conseil d'administration5.4yrs

Mises à jour récentes de la gestion

Recent updates

Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Apr 21
Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors

Apr 16
Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors

Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Mar 17
Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 24
Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?

Nov 29
Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?

Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?

Oct 07
Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?

Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?

Aug 17
Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?

With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case

Jun 20
With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case

A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

May 17
A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate

Dec 27
Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate

Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?

Dec 06
Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?

Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Sep 08
Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?

We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease

Aug 23
We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease

Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless

May 26
Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless

Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching

Apr 29
Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching

An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued

Feb 20
An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Jan 11
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Dec 15
Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Sep 16
Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Jul 05
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Jun 08
Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Mar 23
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Mar 02
Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?

Feb 09
Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?

Surgical Science Sweden AB (publ)'s (STO:SUS) Stock Is Going Strong: Have Financials A Role To Play?

Jan 01
Surgical Science Sweden AB (publ)'s (STO:SUS) Stock Is Going Strong: Have Financials A Role To Play?

What Does Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Indicate?

Dec 14
What Does Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Indicate?

Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Nov 26
Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Analyse de la rémunération des PDG

Comment la rémunération de Gisli Hennermark a-t-elle évolué par rapport aux bénéfices de Surgical Science Sweden?
DateRémunération totaleSalaireBénéfices de l'entreprise
Mar 31 2024n/an/a

SEK 208m

Dec 31 2023SEK 6mSEK 4m

SEK 234m

Sep 30 2023n/an/a

SEK 253m

Jun 30 2023n/an/a

SEK 234m

Mar 31 2023n/an/a

SEK 221m

Dec 31 2022SEK 5mSEK 4m

SEK 188m

Sep 30 2022n/an/a

SEK 138m

Jun 30 2022n/an/a

SEK 124m

Mar 31 2022n/an/a

SEK 101m

Dec 31 2021SEK 4mSEK 3m

SEK 86m

Rémunération vs marché: La rémunération totale de Gisli ($USD 570.73K ) est dans la moyenne des entreprises de taille similaire sur le marché Swedish ($USD 765.82K ).

Rémunération et revenus: La rémunération de Gisli a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Gisli Hennermark (52 yo)

8.9yrs

Titularisation

SEK 5,826,000

Compensation

Mr. Gisli Hennermark serves as Chief Executive Officer of Surgical Science Sweden AB (publ) since September 2015. He serves as board member of Panasari AB and Espansari AB. He worked previously as a manage...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Gisli Hennermark
Chief Executive Officer8.9yrsSEK 5.83m0.67%
SEK 43.3m
Anders Larsson
Co-Founder & CTO5.6yrspas de données0.059%
SEK 3.8m
Anna Ahlberg
Chief Financial Officer6.6yrspas de données0.047%
SEK 3.0m
Boaz Tal
Chief Operating Officer3.6yrspas de données0.036%
SEK 2.3m
Martin Jansson
Head of Global Sales3.6yrspas de donnéespas de données
Inbal Mazor-Badichi
Executive Vice President of Products & Marketing2.8yrspas de données0.036%
SEK 2.3m
Daniel Evestedt
Head of Development4.8yrspas de donnéespas de données
Jeffrey Berkley
Chief Innovation Officer3.5yrspas de donnéespas de données
Ran Bronstein
President of Research & Development2.6yrspas de données0.042%
SEK 2.7m
Doron Zilberman
Executive Vice President of International Sales & Educational Productsno datapas de données0.010%
SEK 650.8k
Niclas Olsson
Executive Vice President of Industry & OEM2.3yrspas de donnéespas de données

3.6yrs

Durée moyenne de l'emploi

55yo

Âge moyen

Gestion expérimentée: L'équipe de direction de SUS est considérée comme expérimentée (ancienneté moyenne 3.6 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Roland Bengtsson
Chairman of the Board19.6yrspas de données11.74%
SEK 757.4m
Jan Bengtsson
Director19.6yrspas de données13.99%
SEK 902.3m
Thomas Eklund
Independent Director7.6yrspas de données0.0020%
SEK 126.4k
Asa Bredin
Independent Director1.3yrspas de données0.00069%
SEK 44.5k
Elisabeth Hansson
Independent Director3.3yrspas de données0.0026%
SEK 164.5k
Henrik Falconer
Independent Director3.3yrspas de données0.0020%
SEK 126.4k

5.4yrs

Durée moyenne de l'emploi

54.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de SUS sont considérés comme expérimentés (ancienneté moyenne 5.4 ans).